Search For "phase 3"
Phase 3 of 'Mission Shakti' to commence in Uttar Pradesh tomorrow
Updated : 4 years, 6 months ago IST
Lucknow (Uttar Pradesh) [India], August 20 (ANI): Uttar Pradesh will commence phase three of Mission Shakti on Saturday with the aim of promoting women safety, respect, self-reliance, informed an official statement by the state government.
Read More
First phase 3 clinical trials of South Korean COVID-19 vaccine: Bioscience
Updated : 4 years, 7 months ago IST
Seoul [South Korea], August 11 (ANI/Global Economic): South Korean Bioscience's vaccine for COVID-19 has entered Phase 3 clinical trials for the first time as the vaccine developed in Korea.
Read More
Biological E's COVID-19 vaccine Corbevax likely to be launched by Septembe
Updated : 4 years, 7 months ago IST
New Delhi [India], July 26 (ANI): The Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine Corbevax by September end in India, said sources on Monday.
Read More
Optimus announces Interim Clinical Results from Phase III Clinical Trials
Updated : 4 years, 7 months ago IST
Hyderabad (Telangana) [India], July 21 (ANI/PNN): Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients.
Read More
Sanofi, GSK receive approval for Phase 3 trial of COVID vaccine in India
Updated : 4 years, 8 months ago IST
New Delhi [India], July 8 (ANI): French pharmaceutical company Sanofi and its British partner GSK (GlaxoSmithKline plc) received approval for their Phase 3 clinical study in India, to assess the safety, efficacy and immunogenicity of their adjuvanted recombinant-protein COVID-19 vaccine cand
Read More
After release of Covaxin's phase 3 efficacy data, NTAGI chief says it will
Updated : 4 years, 8 months ago IST
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Healt
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
Don't need Phase 3 trials, Sputnik Light vaccine can submit Russian safety
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Sputnik vaccine's India-partner Dr Reddy's on Thursday informed that the government panel has told the pharma firm that it does not need to conduct Phase 3 trials for Sputnik Light and only require to submit Russian safety data for approval in India.
Read More
Dr Reddy's denied approval for Phase 3 trials of Sputnik Light Covid-19 va
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The central government's Subject Expert Committee (SEC) has denied permission to Dr Reddy's Laboratories for conducting Phase 3 trials of Russia's COVID-19 vaccine Sputnik Light in India.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 8 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
COVID 19: Over 29.10 crore vaccine doses provided to States/UTs
Updated : 4 years, 8 months ago IST
New Delhi [India], June 20 (ANI): More than 29.10 crore (29,10,54,050) vaccine doses have been provided to States ad Union Territories so far by the central government (free of cost channel) and through direct state procurement category, the Union Health Ministry said.
Read More
Novavax's vaccine, also produced by SII, found 90 pc effective against COV
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): US Biotechnology company Novavax on Monday announced that its Covid-19 vaccine provides 100 per cent protection against moderate and severe symptoms of the disease and 90.4 per cent efficacy overall in phase 3 trials.
Read More